The presidential race captivated millions of TV viewers this week as the first debate took place in Hofstra. But biotech watchers had other races on their mind. Who will be first to market with a new type of cancer treatment known... Read more »
With public interest in artificial intelligence technologies on the rise, five of the world’s largest corporations—vying against each other in so many spheres—are banding together to support research on the ethical and societal issues raised by machines with increasingly human-like capabilities.... Read more »
[Updated 9/29/16, see below] Several promising antipsychotic drugs have made it to late-stage clinical trials only to come up short. Today, you can add an experimental treatment from Intra-Cellular Therapies to the list.
Shares of New York-based Intra-Cellular (NASDAQ:... Read more »
Smart-home technology has gone to the dogs.
New York-based Entrepreneurs Roundtable Accelerator (ERA) graduated 12 startups today, including Dog Parker—a connected doghouse that minds people’s pets while they shop at stores.
That is one example of the broad array of... Read more »
Making the artificial feel more natural is one of the goals of computer scientists these days.
Last week in New York, innovators from IBM, Foursquare, Microsoft, and other companies discussed what may lie ahead in the commercial development of artificial intelligence.... Read more »
Biotech CEO Jonathan Lim co-founded Ignyta in 2011 to commercialize a new approach to diagnosing and treating rheumatoid arthritis, based on discoveries that showed how changes in methyl group molecules associated with the human genome could change the way genes function.... Read more »
A core tenet of Xconomy—and the reason behind our broad coverage across information technology, life sciences, energy, and more—is that the most interesting and important innovations often arise from the intersection of different disciplines.
One of the most important intersections today... Read more »
The FDA approved Monday the first drug ever for Duchenne muscular dystrophy, but only after the commissioner had to settle a high-stakes dispute between powerful agency scientists.
Prominent members of the FDA’s drug-review staff, fearful of setting a precedent for... Read more »
Think “innovation” and you might picture some scrappy entrepreneurs toiling away in a kitchen or garage, hoping the landlord doesn’t notice what they’re up to. But the reality is that turning science into big business often requires far more sophisticated infrastructure—and... Read more »
Today, 10 teams will demo their fintech ideas as the latest batch of startups to come through the Barclays Accelerator in New York.
British bank Barclays and startup accelerator Techstars collaborate to run the program here, with managing director Jenny Fielding... Read more »
A first-of-its-kind fund has launched with the mission to increase diversity in the tech industry by removing financial barriers and increasing access to tech education for anyone interested in pursuing it. The Tech Opportunity Fund is a partnership between the Iron... Read more »
Professor of Media Management, Syracuse University
Product Manager, Foursquare
Co-Founder, Exelixis Inc., and Anadys Pharmaceuticals Inc.
CEO and Co-Founder, Endeavor
President, Rockefeller University
Chairman, EDventure Holdings
Executive Director, NY Tech Meetup and Advisor, Flybridge Capital
President and co-founder of PowerToFly
Founding Partner, General Assembly
President and CEO, Acorda Therapeutics